FDA Import Refusal SCS-4523375-1/10002/1 — BOEHRINGER INGETHEIM INDIA PVTG
The FDA refused shipment SCS-4523375-1/10002/1 from BOEHRINGER INGETHEIM INDIA PVTG (India) on Nov 4, 2025. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charges: 118,3280 This firm has 1 other import refusal on record.
Refusal Details
- Date
- Nov 4, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 118,3280